BOLT
NASDAQ · Biotechnology
Bolt Biotherapeutics Inc
$5.77
+0.37 (+6.85%)
Open$5.94
Previous Close$5.40
Day High$6.14
Day Low$5.41
52W High$24.61
52W Low$11.40
Volume—
Avg Volume488.5K
Market Cap11.08M
P/E Ratio29.54
EPS$0.76
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+357.0% upside
Current
$5.77
$5.77
Target
$26.37
$26.37
$21.16
$26.37 avg
$30.50
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.48M | 3.98M | 4.32M |
| Net Income | 321.1K | 267.7K | 303.4K |
| Profit Margin | 7.2% | 6.7% | 7.0% |
| EBITDA | 558.0K | 477.9K | 559.3K |
| Free Cash Flow | 314.3K | 225.1K | 222.9K |
| Rev Growth | +17.1% | +11.2% | +18.2% |
| Debt/Equity | 0.28 | 0.39 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |